Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Mitochondrial dysfunction in Alzheimer’s disease
202533 citationsM. D’Alessandro, Salim Kanaan et al.Ageing Research Reviewsprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Mauro Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Geller more than expected).
This network shows the impact of papers produced by Mauro Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Geller. The network helps show where Mauro Geller may publish in the future.
Co-authorship network of co-authors of Mauro Geller
This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Geller.
A scholar is included among the top collaborators of Mauro Geller based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mauro Geller. Mauro Geller is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
D’Alessandro, M., et al.. (2025). Mitochondrial dysfunction in Alzheimer’s disease. Ageing Research Reviews. 107. 102713–102713.33 indexed citations breakdown →
Geller, Mauro, et al.. (2020). Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment Outcomes. SHILAP Revista de lepidopterología.4 indexed citations
Lasmar, Ricardo Bassil, et al.. (2014). Premenstrual syndrome: clinical assessment of treatment outcomes following Borago officinalis extract therapy. RBM. Revista brasileira de medicina. 71. 211–217.3 indexed citations
12.
Siqueira‐Batista, Rodrigo, et al.. (2010). NEUROCIÊNCIAS E EDUCAÇÃO:UM TEMPO DE ENCONTRO NO ESPAÇO DOS SABERES. 2(1).1 indexed citations
13.
Nunes, Carlos Pereira, et al.. (2009). Treatment of inflammatory neuropathy with dexamethasone plus B-vitamins: a clinical evaluation. RBM. Revista brasileira de medicina. 66(6). 169–173.1 indexed citations
14.
Nunes, Carlos Pereira, Spyros G.E. Mezitis, João Paulo Lima Daher, et al.. (2009). Osteoarthritis: clinical evaluation of diclofenac combined with the B complex vitamins. RBM. Revista brasileira de medicina. 66(7). 206–212.2 indexed citations
15.
Geller, Mauro, et al.. (2008). Recurrent urinary tract infections: Evaluation of the prophylactic efficacy of urinary antiseptics methenamine and methylthioninium chloride. RBM. Revista brasileira de medicina. 65(11). 367–371.1 indexed citations
16.
Krymchantowski, Abouch Valenty, et al.. (2007). Evaluation of the safety and efficacy of an injectable B-vitamin combination in acute neuralgias. RBM. Revista brasileira de medicina. 64(3). 138–141.1 indexed citations
17.
Geller, Mauro, et al.. (2006). Therapeutic properties of the B-complex vitamins (B1, B6, B12) and their pharmacologic associations. RBM. Revista brasileira de medicina. 63(3). 111–117.1 indexed citations
18.
Ribeiro, Márcia Gonçalves, et al.. (2004). Safety and efficacy of a combination of dexamethasone plus B-vitamins in the treatment of inflammatory neuropathies. RBM. Revista brasileira de medicina. 64(4). 177–181.1 indexed citations
19.
Geller, Mauro, et al.. (1999). Neurofibromatose (Síndrome de Von Recklinghausen): 3 Genética e NF2. 36–39.1 indexed citations
20.
Geller, Mauro, et al.. (1998). Neurofibromatose: Síndrome de Von Recklinghausen: histórico, diagnósticos, exames clínicos e laboratoriais. 15–21.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.